Login / Signup

Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study.

Anna GazzolaMohsen NavariClaudia MannuRiccardo DonelliMaryam EtebariPier Paolo Piccaluga
Published in: Cancers (2023)
Overall, conventional Sanger sequencing and next-generation-sequencing-based clonality and somatic hypermutation analyses gave comparable results. For future use in a routine diagnostic workflow, NGS-based approaches should be evaluated prospectively and an analysis of cost-effectiveness should be performed.
Keyphrases
  • copy number
  • phase iii
  • open label
  • clinical trial
  • single cell
  • clinical practice